Global Rare Hematology Market Growth (Status and Outlook) 2025-2031

February 2025 | 85 pages | ID: G7D509A87638EN
LP Information

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rare Hematology Market Size (2020-2031)
  2.1.2 Rare Hematology Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Rare Hematology by Country/Region (2020, 2024 & 2031)
2.2 Rare Hematology Segment by Type
  2.2.1 Recombinant Factors
  2.2.2 Plasma Derived Factors
2.3 Rare Hematology Market Size by Type
  2.3.1 Rare Hematology Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Rare Hematology Market Size Market Share by Type (2020-2025)
2.4 Rare Hematology Segment by Application
  2.4.1 Pediatric
  2.4.2 Adult
2.5 Rare Hematology Market Size by Application
  2.5.1 Rare Hematology Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Rare Hematology Market Size Market Share by Application (2020-2025)

3 RARE HEMATOLOGY MARKET SIZE BY PLAYER

3.1 Rare Hematology Market Size Market Share by Player
  3.1.1 Global Rare Hematology Revenue by Player (2020-2025)
  3.1.2 Global Rare Hematology Revenue Market Share by Player (2020-2025)
3.2 Global Rare Hematology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RARE HEMATOLOGY BY REGION

4.1 Rare Hematology Market Size by Region (2020-2025)
4.2 Global Rare Hematology Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rare Hematology Market Size Growth (2020-2025)
4.4 APAC Rare Hematology Market Size Growth (2020-2025)
4.5 Europe Rare Hematology Market Size Growth (2020-2025)
4.6 Middle East & Africa Rare Hematology Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Rare Hematology Market Size by Country (2020-2025)
5.2 Americas Rare Hematology Market Size by Type (2020-2025)
5.3 Americas Rare Hematology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rare Hematology Market Size by Region (2020-2025)
6.2 APAC Rare Hematology Market Size by Type (2020-2025)
6.3 APAC Rare Hematology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Rare Hematology Market Size by Country (2020-2025)
7.2 Europe Rare Hematology Market Size by Type (2020-2025)
7.3 Europe Rare Hematology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rare Hematology by Region (2020-2025)
8.2 Middle East & Africa Rare Hematology Market Size by Type (2020-2025)
8.3 Middle East & Africa Rare Hematology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RARE HEMATOLOGY MARKET FORECAST

10.1 Global Rare Hematology Forecast by Region (2026-2031)
  10.1.1 Global Rare Hematology Forecast by Region (2026-2031)
  10.1.2 Americas Rare Hematology Forecast
  10.1.3 APAC Rare Hematology Forecast
  10.1.4 Europe Rare Hematology Forecast
  10.1.5 Middle East & Africa Rare Hematology Forecast
10.2 Americas Rare Hematology Forecast by Country (2026-2031)
  10.2.1 United States Market Rare Hematology Forecast
  10.2.2 Canada Market Rare Hematology Forecast
  10.2.3 Mexico Market Rare Hematology Forecast
  10.2.4 Brazil Market Rare Hematology Forecast
10.3 APAC Rare Hematology Forecast by Region (2026-2031)
  10.3.1 China Rare Hematology Market Forecast
  10.3.2 Japan Market Rare Hematology Forecast
  10.3.3 Korea Market Rare Hematology Forecast
  10.3.4 Southeast Asia Market Rare Hematology Forecast
  10.3.5 India Market Rare Hematology Forecast
  10.3.6 Australia Market Rare Hematology Forecast
10.4 Europe Rare Hematology Forecast by Country (2026-2031)
  10.4.1 Germany Market Rare Hematology Forecast
  10.4.2 France Market Rare Hematology Forecast
  10.4.3 UK Market Rare Hematology Forecast
  10.4.4 Italy Market Rare Hematology Forecast
  10.4.5 Russia Market Rare Hematology Forecast
10.5 Middle East & Africa Rare Hematology Forecast by Region (2026-2031)
  10.5.1 Egypt Market Rare Hematology Forecast
  10.5.2 South Africa Market Rare Hematology Forecast
  10.5.3 Israel Market Rare Hematology Forecast
  10.5.4 Turkey Market Rare Hematology Forecast
10.6 Global Rare Hematology Forecast by Type (2026-2031)
10.7 Global Rare Hematology Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Rare Hematology Forecast

11 KEY PLAYERS ANALYSIS

11.1 Takeda
  11.1.1 Takeda Company Information
  11.1.2 Takeda Rare Hematology Product Offered
  11.1.3 Takeda Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Takeda Main Business Overview
  11.1.5 Takeda Latest Developments
11.2 Novo Nordisk A/S
  11.2.1 Novo Nordisk A/S Company Information
  11.2.2 Novo Nordisk A/S Rare Hematology Product Offered
  11.2.3 Novo Nordisk A/S Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novo Nordisk A/S Main Business Overview
  11.2.5 Novo Nordisk A/S Latest Developments
11.3 Pfizer Inc.
  11.3.1 Pfizer Inc. Company Information
  11.3.2 Pfizer Inc. Rare Hematology Product Offered
  11.3.3 Pfizer Inc. Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer Inc. Main Business Overview
  11.3.5 Pfizer Inc. Latest Developments
11.4 Bayer Healthcare AG
  11.4.1 Bayer Healthcare AG Company Information
  11.4.2 Bayer Healthcare AG Rare Hematology Product Offered
  11.4.3 Bayer Healthcare AG Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bayer Healthcare AG Main Business Overview
  11.4.5 Bayer Healthcare AG Latest Developments
11.5 CSL Behring LLC
  11.5.1 CSL Behring LLC Company Information
  11.5.2 CSL Behring LLC Rare Hematology Product Offered
  11.5.3 CSL Behring LLC Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 CSL Behring LLC Main Business Overview
  11.5.5 CSL Behring LLC Latest Developments
11.6 Biogen Inc.
  11.6.1 Biogen Inc. Company Information
  11.6.2 Biogen Inc. Rare Hematology Product Offered
  11.6.3 Biogen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Biogen Inc. Main Business Overview
  11.6.5 Biogen Inc. Latest Developments
11.7 Alexion Pharmaceuticals
  11.7.1 Alexion Pharmaceuticals Company Information
  11.7.2 Alexion Pharmaceuticals Rare Hematology Product Offered
  11.7.3 Alexion Pharmaceuticals Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Alexion Pharmaceuticals Main Business Overview
  11.7.5 Alexion Pharmaceuticals Latest Developments
11.8 Celgene Corporation
  11.8.1 Celgene Corporation Company Information
  11.8.2 Celgene Corporation Rare Hematology Product Offered
  11.8.3 Celgene Corporation Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Celgene Corporation Main Business Overview
  11.8.5 Celgene Corporation Latest Developments
11.9 Amgen Inc.
  11.9.1 Amgen Inc. Company Information
  11.9.2 Amgen Inc. Rare Hematology Product Offered
  11.9.3 Amgen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Amgen Inc. Main Business Overview
  11.9.5 Amgen Inc. Latest Developments
11.10 PRA Health Sciences
  11.10.1 PRA Health Sciences Company Information
  11.10.2 PRA Health Sciences Rare Hematology Product Offered
  11.10.3 PRA Health Sciences Rare Hematology Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 PRA Health Sciences Main Business Overview
  11.10.5 PRA Health Sciences Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rare Hematology Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Rare Hematology Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of RecombinantFactors
Table 4. Major Players of Plasma DerivedFactors
Table 5. Rare Hematology Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Rare Hematology Market Size byType (2020-2025) & ($ millions)
Table 7. Global Rare Hematology Market Size Market Share byType (2020-2025)
Table 8. Rare Hematology Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Rare Hematology Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Rare Hematology Market Size Market Share by Application (2020-2025)
Table 11. Global Rare Hematology Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Rare Hematology Revenue Market Share by Player (2020-2025)
Table 13. Rare Hematology Key Players Head office and Products Offered
Table 14. Rare Hematology Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Rare Hematology Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Rare Hematology Market Size Market Share by Region (2020-2025)
Table 19. Global Rare Hematology Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Rare Hematology Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Rare Hematology Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Rare Hematology Market Size Market Share by Country (2020-2025)
Table 23. Americas Rare Hematology Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Rare Hematology Market Size Market Share byType (2020-2025)
Table 25. Americas Rare Hematology Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Rare Hematology Market Size Market Share by Application (2020-2025)
Table 27. APAC Rare Hematology Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Rare Hematology Market Size Market Share by Region (2020-2025)
Table 29. APAC Rare Hematology Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Rare Hematology Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Rare Hematology Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Rare Hematology Market Size Market Share by Country (2020-2025)
Table 33. Europe Rare Hematology Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Rare Hematology Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Rare Hematology Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Rare Hematology Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Rare Hematology Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Rare Hematology
Table 39. Key Market Challenges & Risks of Rare Hematology
Table 40. Key IndustryTrends of Rare Hematology
Table 41. Global Rare Hematology Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Rare Hematology Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Rare Hematology Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Rare Hematology Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45.Takeda Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 46.Takeda Rare Hematology Product Offered
Table 47.Takeda Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48.Takeda Main Business
Table 49.Takeda Latest Developments
Table 50. Novo Nordisk A/S Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 51. Novo Nordisk A/S Rare Hematology Product Offered
Table 52. Novo Nordisk A/S Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novo Nordisk A/S Main Business
Table 54. Novo Nordisk A/S Latest Developments
Table 55. Pfizer Inc. Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 56. Pfizer Inc. Rare Hematology Product Offered
Table 57. Pfizer Inc. Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Pfizer Inc. Main Business
Table 59. Pfizer Inc. Latest Developments
Table 60. Bayer Healthcare AG Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 61. Bayer Healthcare AG Rare Hematology Product Offered
Table 62. Bayer Healthcare AG Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bayer Healthcare AG Main Business
Table 64. Bayer Healthcare AG Latest Developments
Table 65. CSL Behring LLC Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 66. CSL Behring LLC Rare Hematology Product Offered
Table 67. CSL Behring LLC Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. CSL Behring LLC Main Business
Table 69. CSL Behring LLC Latest Developments
Table 70. Biogen Inc. Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 71. Biogen Inc. Rare Hematology Product Offered
Table 72. Biogen Inc. Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Biogen Inc. Main Business
Table 74. Biogen Inc. Latest Developments
Table 75. Alexion Pharmaceuticals Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 76. Alexion Pharmaceuticals Rare Hematology Product Offered
Table 77. Alexion Pharmaceuticals Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Alexion Pharmaceuticals Main Business
Table 79. Alexion Pharmaceuticals Latest Developments
Table 80. Celgene Corporation Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 81. Celgene Corporation Rare Hematology Product Offered
Table 82. Celgene Corporation Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Celgene Corporation Main Business
Table 84. Celgene Corporation Latest Developments
Table 85. Amgen Inc. Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 86. Amgen Inc. Rare Hematology Product Offered
Table 87. Amgen Inc. Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Amgen Inc. Main Business
Table 89. Amgen Inc. Latest Developments
Table 90. PRA Health Sciences Details, CompanyType, Rare Hematology Area Served and Its Competitors
Table 91. PRA Health Sciences Rare Hematology Product Offered
Table 92. PRA Health Sciences Rare Hematology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. PRA Health Sciences Main Business
Table 94. PRA Health Sciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Rare Hematology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rare Hematology Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Rare Hematology Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Rare Hematology Sales Market Share by Country/Region (2024)
Figure 8. Rare Hematology Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Rare Hematology Market Size Market Share byType in 2024
Figure 10. Rare Hematology in Pediatric
Figure 11. Global Rare Hematology Market: Pediatric (2020-2025) & ($ millions)
Figure 12. Rare Hematology in Adult
Figure 13. Global Rare Hematology Market: Adult (2020-2025) & ($ millions)
Figure 14. Global Rare Hematology Market Size Market Share by Application in 2024
Figure 15. Global Rare Hematology Revenue Market Share by Player in 2024
Figure 16. Global Rare Hematology Market Size Market Share by Region (2020-2025)
Figure 17. Americas Rare Hematology Market Size 2020-2025 ($ millions)
Figure 18. APAC Rare Hematology Market Size 2020-2025 ($ millions)
Figure 19. Europe Rare Hematology Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Rare Hematology Market Size 2020-2025 ($ millions)
Figure 21. Americas Rare Hematology Value Market Share by Country in 2024
Figure 22. United States Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Rare Hematology Market Size Market Share by Region in 2024
Figure 27. APAC Rare Hematology Market Size Market Share byType (2020-2025)
Figure 28. APAC Rare Hematology Market Size Market Share by Application (2020-2025)
Figure 29. China Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 33. India Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Rare Hematology Market Size Market Share by Country in 2024
Figure 36. Europe Rare Hematology Market Size Market Share byType (2020-2025)
Figure 37. Europe Rare Hematology Market Size Market Share by Application (2020-2025)
Figure 38. Germany Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 39.France Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Rare Hematology Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Rare Hematology Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Rare Hematology Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Rare Hematology Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Rare Hematology Market Size 2026-2031 ($ millions)
Figure 52. APAC Rare Hematology Market Size 2026-2031 ($ millions)
Figure 53. Europe Rare Hematology Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Rare Hematology Market Size 2026-2031 ($ millions)
Figure 55. United States Rare Hematology Market Size 2026-2031 ($ millions)
Figure 56. Canada Rare Hematology Market Size 2026-2031 ($ millions)
Figure 57. Mexico Rare Hematology Market Size 2026-2031 ($ millions)
Figure 58. Brazil Rare Hematology Market Size 2026-2031 ($ millions)
Figure 59. China Rare Hematology Market Size 2026-2031 ($ millions)
Figure 60. Japan Rare Hematology Market Size 2026-2031 ($ millions)
Figure 61. Korea Rare Hematology Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Rare Hematology Market Size 2026-2031 ($ millions)
Figure 63. India Rare Hematology Market Size 2026-2031 ($ millions)
Figure 64. Australia Rare Hematology Market Size 2026-2031 ($ millions)
Figure 65. Germany Rare Hematology Market Size 2026-2031 ($ millions)
Figure 66.France Rare Hematology Market Size 2026-2031 ($ millions)
Figure 67. UK Rare Hematology Market Size 2026-2031 ($ millions)
Figure 68. Italy Rare Hematology Market Size 2026-2031 ($ millions)
Figure 69. Russia Rare Hematology Market Size 2026-2031 ($ millions)
Figure 70. Egypt Rare Hematology Market Size 2026-2031 ($ millions)
Figure 71. South Africa Rare Hematology Market Size 2026-2031 ($ millions)
Figure 72. Israel Rare Hematology Market Size 2026-2031 ($ millions)
Figure 73.Turkey Rare Hematology Market Size 2026-2031 ($ millions)
Figure 74. Global Rare Hematology Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Rare Hematology Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Rare Hematology Market Size 2026-2031 ($ millions)